Search research articles
Contact Us
Filters
Showing results (261-270 of 300) with videos related to
Page
of 30
Sort By:
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood Cancer Journal
|
January 28, 2026
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
Eva Domingo-Domènech, Barbara Pro, Tim Illidge, et al.
Blood Cancer Journal
|
August 1, 2025
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
Eva Domingo-Domènech, Barbara Pro, Tim Illidge, et al.
Blood Advances
|
January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Monika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
British Journal of Haematology
|
April 19, 2017
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma
Peter Martin, Zhengming Chen, Bruce D Cheson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials
Sarah C Rutherford, Jun Yin, Levi Pederson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
American Journal of Hematology
|
June 4, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma
Zhengming Chen, Danny Luan, Rasmus Rask Kragh Jørgensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Hematological Oncology
|
October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
James R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 300) with videos related to
Sort By:
Page
of 30
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood Cancer Journal
|
January 28, 2026
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
Eva Domingo-Domènech, Barbara Pro, Tim Illidge, et al.
Blood Cancer Journal
|
August 1, 2025
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
Eva Domingo-Domènech, Barbara Pro, Tim Illidge, et al.
Blood Advances
|
January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Monika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
British Journal of Haematology
|
April 19, 2017
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma
Peter Martin, Zhengming Chen, Bruce D Cheson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials
Sarah C Rutherford, Jun Yin, Levi Pederson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
American Journal of Hematology
|
June 4, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma
Zhengming Chen, Danny Luan, Rasmus Rask Kragh Jørgensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Hematological Oncology
|
October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
James R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Page
of 30